Given the early findings and pharmacological superiority of GLP-1R agonists in neurological pathophysiology, we hypothesized that GLP-1R activation could inhibit pyroptosis of microglia, subsequently reducing neuroinflammation in diabetes with depression. The gene discussed is GLP1R; the disease is depressive disorder.